Colorectal cancer is the third most common type cancer and represents 9.7% of total cancer cases across the globe. According to American Cancer Society colorectal cancer is treatable and curable when it is localized to the bowel. However, colorectal cancer cancers that have spread to other body parts i.e. metastatic colorectal cancers are difficult to treat and have 11%-12% 5-year relative survival rate.
This report aims to provide a comprehensive presentation of the global market for Metastatic Colorectal Cancer Surgery, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Metastatic Colorectal Cancer Surgery. This report contains market size and forecasts of Metastatic Colorectal Cancer Surgery in global, including the following market information:
Global Metastatic Colorectal Cancer Surgery Market Revenue, 2018-2023, 2024-2035, ($ millions)
Global top five companies in 2022 (%)
The global Metastatic Colorectal Cancer Surgery market was valued at US$ million in 2022 and is projected to reach US$ million by 2035, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Treatment of metastatic colorectal cancer is multidisciplinary field involving early evaluation for resection of hepatic metastasis, metastasectomy and coordinated chemotherapy or radiation therapy. Primary factors driving growth of metastatic colorectal cancer treatment market are increasing prevalence of colorectal cancer across the globe, rapid innovation in personalized medicine and discovery of new targets for treatment of colorectal cancers.
We surveyed the Metastatic Colorectal Cancer Surgery companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Metastatic Colorectal Cancer Surgery Market, by Type, 2018-2023, 2024-2035 ($ millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Type, 2022 (%)
Tumor Resection
Portal Vein Embolization
Global Metastatic Colorectal Cancer Surgery Market, by Application, 2018-2023, 2024-2035 ($ millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, by Application, 2022 (%)
Hospitals
Clinics
Cancer Research Centers
Global Metastatic Colorectal Cancer Surgery Market, By Region and Country, 2018-2023, 2024-2035 ($ Millions)
Global Metastatic Colorectal Cancer Surgery Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Metastatic Colorectal Cancer Surgery revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Metastatic Colorectal Cancer Surgery revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sanofi
Roche
Eli Lilly
Pfizer
Novartis
Amgen
Taiho Oncology
Genentech
EMD Serono
Suzhou Zelgen Biopharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Metastatic Colorectal Cancer Surgery, market overview.
Chapter 2: Global Metastatic Colorectal Cancer Surgery market size in revenue.
Chapter 3: Detailed analysis of Metastatic Colorectal Cancer Surgery company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Metastatic Colorectal Cancer Surgery in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Metastatic Colorectal Cancer Surgery Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Metastatic Colorectal Cancer Surgery Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Metastatic Colorectal Cancer Surgery Overall Market Size
2.1 Global Metastatic Colorectal Cancer Surgery Market Size: 2022 VS 2035
2.2 Global Metastatic Colorectal Cancer Surgery Market Size, Prospects & Forecasts: 2018-2035
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Metastatic Colorectal Cancer Surgery Players in Global Market
3.2 Top Global Metastatic Colorectal Cancer Surgery Companies Ranked by Revenue
3.3 Global Metastatic Colorectal Cancer Surgery Revenue by Companies
3.4 Top 3 and Top 5 Metastatic Colorectal Cancer Surgery Companies in Global Market, by Revenue in 2022
3.5 Global Companies Metastatic Colorectal Cancer Surgery Product Type
3.6 Tier 1, Tier 2 and Tier 3 Metastatic Colorectal Cancer Surgery Players in Global Market
3.6.1 List of Global Tier 1 Metastatic Colorectal Cancer Surgery Companies
3.6.2 List of Global Tier 2 and Tier 3 Metastatic Colorectal Cancer Surgery Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Metastatic Colorectal Cancer Surgery Market Size Markets, 2022 & 2035
4.1.2 Tumor Resection
4.1.3 Portal Vein Embolization
4.2 By Type - Global Metastatic Colorectal Cancer Surgery Revenue & Forecasts
4.2.1 By Type - Global Metastatic Colorectal Cancer Surgery Revenue, 2018-2023
4.2.2 By Type - Global Metastatic Colorectal Cancer Surgery Revenue, 2024-2035
4.2.3 By Type - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Metastatic Colorectal Cancer Surgery Market Size, 2022 & 2035
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Cancer Research Centers
5.2 By Application - Global Metastatic Colorectal Cancer Surgery Revenue & Forecasts
5.2.1 By Application - Global Metastatic Colorectal Cancer Surgery Revenue, 2018-2023
5.2.2 By Application - Global Metastatic Colorectal Cancer Surgery Revenue, 2024-2035
5.2.3 By Application - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
6 Sights by Region
6.1 By Region - Global Metastatic Colorectal Cancer Surgery Market Size, 2022 & 2035
6.2 By Region - Global Metastatic Colorectal Cancer Surgery Revenue & Forecasts
6.2.1 By Region - Global Metastatic Colorectal Cancer Surgery Revenue, 2018-2023
6.2.2 By Region - Global Metastatic Colorectal Cancer Surgery Revenue, 2024-2035
6.2.3 By Region - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
6.3 North America
6.3.1 By Country - North America Metastatic Colorectal Cancer Surgery Revenue, 2018-2035
6.3.2 US Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.3.3 Canada Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.3.4 Mexico Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4 Europe
6.4.1 By Country - Europe Metastatic Colorectal Cancer Surgery Revenue, 2018-2035
6.4.2 Germany Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.3 France Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.4 U.K. Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.5 Italy Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.6 Russia Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.7 Nordic Countries Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.4.8 Benelux Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.5 Asia
6.5.1 By Region - Asia Metastatic Colorectal Cancer Surgery Revenue, 2018-2035
6.5.2 China Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.5.3 Japan Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.5.4 South Korea Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.5.5 Southeast Asia Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.5.6 India Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.6 South America
6.6.1 By Country - South America Metastatic Colorectal Cancer Surgery Revenue, 2018-2035
6.6.2 Brazil Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.6.3 Argentina Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Metastatic Colorectal Cancer Surgery Revenue, 2018-2035
6.7.2 Turkey Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.7.3 Israel Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.7.4 Saudi Arabia Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
6.7.5 UAE Metastatic Colorectal Cancer Surgery Market Size, 2018-2035
7 Metastatic Colorectal Cancer Surgery Companies Profiles
7.1 Sanofi
7.1.1 Sanofi Company Summary
7.1.2 Sanofi Business Overview
7.1.3 Sanofi Metastatic Colorectal Cancer Surgery Major Product Offerings
7.1.4 Sanofi Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.1.5 Sanofi Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Metastatic Colorectal Cancer Surgery Major Product Offerings
7.2.4 Roche Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 Eli Lilly
7.3.1 Eli Lilly Company Summary
7.3.2 Eli Lilly Business Overview
7.3.3 Eli Lilly Metastatic Colorectal Cancer Surgery Major Product Offerings
7.3.4 Eli Lilly Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.3.5 Eli Lilly Key News & Latest Developments
7.4 Pfizer
7.4.1 Pfizer Company Summary
7.4.2 Pfizer Business Overview
7.4.3 Pfizer Metastatic Colorectal Cancer Surgery Major Product Offerings
7.4.4 Pfizer Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.4.5 Pfizer Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Metastatic Colorectal Cancer Surgery Major Product Offerings
7.5.4 Novartis Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Metastatic Colorectal Cancer Surgery Major Product Offerings
7.6.4 Amgen Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Taiho Oncology
7.7.1 Taiho Oncology Company Summary
7.7.2 Taiho Oncology Business Overview
7.7.3 Taiho Oncology Metastatic Colorectal Cancer Surgery Major Product Offerings
7.7.4 Taiho Oncology Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.7.5 Taiho Oncology Key News & Latest Developments
7.8 Genentech
7.8.1 Genentech Company Summary
7.8.2 Genentech Business Overview
7.8.3 Genentech Metastatic Colorectal Cancer Surgery Major Product Offerings
7.8.4 Genentech Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.8.5 Genentech Key News & Latest Developments
7.9 EMD Serono
7.9.1 EMD Serono Company Summary
7.9.2 EMD Serono Business Overview
7.9.3 EMD Serono Metastatic Colorectal Cancer Surgery Major Product Offerings
7.9.4 EMD Serono Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.9.5 EMD Serono Key News & Latest Developments
7.10 Suzhou Zelgen Biopharmaceuticals
7.10.1 Suzhou Zelgen Biopharmaceuticals Company Summary
7.10.2 Suzhou Zelgen Biopharmaceuticals Business Overview
7.10.3 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Major Product Offerings
7.10.4 Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Revenue in Global Market (2018-2023)
7.10.5 Suzhou Zelgen Biopharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Metastatic Colorectal Cancer Surgery Market Opportunities & Trends in Global Market
Table 2. Metastatic Colorectal Cancer Surgery Market Drivers in Global Market
Table 3. Metastatic Colorectal Cancer Surgery Market Restraints in Global Market
Table 4. Key Players of Metastatic Colorectal Cancer Surgery in Global Market
Table 5. Top Metastatic Colorectal Cancer Surgery Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Metastatic Colorectal Cancer Surgery Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Metastatic Colorectal Cancer Surgery Revenue Share by Companies, 2018-2023
Table 8. Global Companies Metastatic Colorectal Cancer Surgery Product Type
Table 9. List of Global Tier 1 Metastatic Colorectal Cancer Surgery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Metastatic Colorectal Cancer Surgery Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2022 & 2035
Table 12. By Type - Metastatic Colorectal Cancer Surgery Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Metastatic Colorectal Cancer Surgery Revenue in Global (US$, Mn), 2024-2035
Table 14. By Application ? Global Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2022 & 2035
Table 15. By Application - Metastatic Colorectal Cancer Surgery Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Metastatic Colorectal Cancer Surgery Revenue in Global (US$, Mn), 2024-2035
Table 17. By Region ? Global Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2022 & 2035
Table 18. By Region - Global Metastatic Colorectal Cancer Surgery Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Metastatic Colorectal Cancer Surgery Revenue (US$, Mn), 2024-2035
Table 20. By Country - North America Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2024-2035
Table 22. By Country - Europe Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2024-2035
Table 24. By Region - Asia Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2024-2035
Table 26. By Country - South America Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2024-2035
Table 28. By Country - Middle East & Africa Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2024-2035
Table 30. Sanofi Company Summary
Table 31. Sanofi Metastatic Colorectal Cancer Surgery Product Offerings
Table 32. Sanofi Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 33. Sanofi Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Metastatic Colorectal Cancer Surgery Product Offerings
Table 36. Roche Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. Eli Lilly Company Summary
Table 39. Eli Lilly Metastatic Colorectal Cancer Surgery Product Offerings
Table 40. Eli Lilly Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 41. Eli Lilly Key News & Latest Developments
Table 42. Pfizer Company Summary
Table 43. Pfizer Metastatic Colorectal Cancer Surgery Product Offerings
Table 44. Pfizer Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 45. Pfizer Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Metastatic Colorectal Cancer Surgery Product Offerings
Table 48. Novartis Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Metastatic Colorectal Cancer Surgery Product Offerings
Table 52. Amgen Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Taiho Oncology Company Summary
Table 55. Taiho Oncology Metastatic Colorectal Cancer Surgery Product Offerings
Table 56. Taiho Oncology Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 57. Taiho Oncology Key News & Latest Developments
Table 58. Genentech Company Summary
Table 59. Genentech Metastatic Colorectal Cancer Surgery Product Offerings
Table 60. Genentech Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 61. Genentech Key News & Latest Developments
Table 62. EMD Serono Company Summary
Table 63. EMD Serono Metastatic Colorectal Cancer Surgery Product Offerings
Table 64. EMD Serono Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 65. EMD Serono Key News & Latest Developments
Table 66. Suzhou Zelgen Biopharmaceuticals Company Summary
Table 67. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Product Offerings
Table 68. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Revenue (US$, Mn) & (2018-2023)
Table 69. Suzhou Zelgen Biopharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Metastatic Colorectal Cancer Surgery Segment by Type in 2022
Figure 2. Metastatic Colorectal Cancer Surgery Segment by Application in 2022
Figure 3. Global Metastatic Colorectal Cancer Surgery Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Metastatic Colorectal Cancer Surgery Market Size: 2022 VS 2035 (US$, Mn)
Figure 6. Global Metastatic Colorectal Cancer Surgery Revenue, 2018-2035 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Metastatic Colorectal Cancer Surgery Revenue in 2022
Figure 8. By Type - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 9. By Application - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 10. By Type - Global Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2022 & 2035
Figure 11. By Type - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 12. By Application - Global Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2022 & 2035
Figure 13. By Application - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 14. By Region - Global Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 15. By Country - North America Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 16. US Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 17. Canada Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 18. Mexico Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 19. By Country - Europe Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 20. Germany Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 21. France Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 22. U.K. Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 23. Italy Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 24. Russia Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 25. Nordic Countries Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 26. Benelux Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 27. By Region - Asia Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 28. China Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 29. Japan Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 30. South Korea Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 31. Southeast Asia Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 32. India Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 33. By Country - South America Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 34. Brazil Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 35. Argentina Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 36. By Country - Middle East & Africa Metastatic Colorectal Cancer Surgery Revenue Market Share, 2018-2035
Figure 37. Turkey Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 38. Israel Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 39. Saudi Arabia Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 40. UAE Metastatic Colorectal Cancer Surgery Revenue, (US$, Mn), 2018-2035
Figure 41. Sanofi Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Eli Lilly Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Pfizer Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Taiho Oncology Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Genentech Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. EMD Serono Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Suzhou Zelgen Biopharmaceuticals Metastatic Colorectal Cancer Surgery Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
